A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

CompletedOBSERVATIONAL

Enrollment

674

Participants

Timeline

Start Date

December 21, 2010

Primary Completion Date

June 27, 2016

Study Completion Date

August 18, 2016

Conditions

Hypertension

Interventions

DRUG

Twynsta tablet

Telmisartan and Amlodipine T40/A5, T80/A5 and T40/A10

Trial Locations (1)

NISND Center, One Or Multiple Sites